The Pakistan-China Pharma Conference will feature B2B meetings and investment sessions, playing a key role in industrial cooperation and technology transfer.
Islamabad: (RightNow) New avenues for modern technology and investment in Pakistan’s health and pharma sector are opening. The Pakistan-China Pharmaceutical Conference is being organized in collaboration with SIFC, the Federal Ministry of Health, and the Drug Regulatory Authority.
The conference will be held on July 17 and 18, promoting industrial cooperation in the pharmaceutical sector between Pakistan and China. It will include business-to-business meetings and investment-related sessions.
The aim of the conference is to discuss local production, joint ventures, and research collaboration. Opportunities for technology transfer and contract manufacturing will also be considered during the event.
This conference will play a crucial role in modernizing Pakistan’s healthcare system and enhancing the competitiveness of the pharmaceutical industry. Organized with SIFC’s support, it will further strengthen the Pakistan-China partnership.
It is noteworthy that the Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference is being held to promote economic relations between the two countries.
